Moreover, miR-29 was found upregulated in CLL cases compared to healthy individuals suggesting that it can act as an additional oncomiR; its expression was correlated to that of TCL1, a known oncogene with a crucial role in aggressive CLL cases. Here, TCL1A is linked to B-cell chronic lymphocytic leukemia.